Key Events This Week
Feb 9: Stock opens at Rs.106.15, gaining 2.12% on strong volume
Feb 10: Q3 FY26 results reveal profit surge amid margin pressures
Feb 11: Positive financial trend reported; stock hits intraweek high of Rs.109.05
Feb 12-13: Profit-taking leads to declines; week closes at Rs.104.65
Monday, 9 February: Strong Start on Market Rally
Amanta Healthcare began the week on a positive note, closing at Rs.106.15, up 2.12% from the previous Friday’s close of Rs.103.95. This gain outpaced the Sensex’s 1.04% rise to 37,113.23, signalling early investor optimism. The volume of 878 shares, though modest, supported the price appreciation as the broader market rallied on positive sentiment.
Tuesday, 10 February: Earnings Reveal Profit Surge Amid Margin Pressures
The company released its Q3 FY26 results, highlighting a significant profit surge despite underlying margin pressures. The stock edged higher by 0.38% to Rs.106.55 on robust volume of 7,761 shares, reflecting cautious investor approval of the quarterly performance. The Sensex also advanced 0.25% to 37,207.34, but Amanta’s outperformance was notable given the mixed earnings environment in the pharmaceutical sector.
Wednesday, 11 February: Positive Financial Trend Boosts Stock to Weekly High
Amanta Healthcare reported a strong quarterly upswing with net sales reaching ₹74.49 crores, the highest in recent quarters, and a 73.88% year-on-year PAT growth to ₹10.75 crores for the nine months ended December 2025. The operating profit to interest ratio improved to 3.04 times, signalling enhanced financial health. These factors contributed to a positive financial trend score of 6, upgraded from neutral three months prior.
The stock responded with a 2.35% gain, closing at Rs.109.05, its weekly high, on volume of 4,337 shares. This outpaced the Sensex’s marginal 0.13% rise to 37,256.72, underscoring investor confidence in the company’s operational turnaround despite ongoing sector challenges.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Thursday, 12 February: Profit-Taking Amid Market Weakness
Following the midweek gains, Amanta Healthcare’s stock retreated 0.50% to Rs.108.50 on lower volume of 2,118 shares. The decline coincided with a 0.56% drop in the Sensex to 37,049.40, reflecting broader market weakness. The pullback suggests some investors booked profits after the strong quarterly results, though the stock remained well above its week’s opening level.
Friday, 13 February: Sharp Decline Caps Week on Negative Market Sentiment
The stock closed the week with a notable 3.55% decline to Rs.104.65 on subdued volume of 1,020 shares. This drop was sharper than the Sensex’s 1.40% fall to 36,532.48, indicating some sector-specific pressures or profit-taking at week’s end. Despite this, the stock managed a weekly gain of 0.67%, outperforming the benchmark by 1.21 percentage points.
Holding Amanta Healthcare Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Weekly Price Performance: Amanta Healthcare vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-09 | Rs.106.15 | +2.12% | 37,113.23 | +1.04% |
| 2026-02-10 | Rs.106.55 | +0.38% | 37,207.34 | +0.25% |
| 2026-02-11 | Rs.109.05 | +2.35% | 37,256.72 | +0.13% |
| 2026-02-12 | Rs.108.50 | -0.50% | 37,049.40 | -0.56% |
| 2026-02-13 | Rs.104.65 | -3.55% | 36,532.48 | -1.40% |
Key Takeaways
Positive Signals: Amanta Healthcare’s quarterly results demonstrated robust revenue growth to ₹74.49 crores and a substantial 73.88% increase in PAT for the nine months ended December 2025. The operating profit to interest coverage ratio improved to 3.04 times, signalling stronger financial health. The positive financial trend score upgrade to 6 reflects operational improvements and margin expansion despite sector challenges. The stock’s weekly gain of 0.67% outperformed the Sensex’s 0.54% decline, highlighting relative strength.
Cautionary Notes: The latter part of the week saw profit-taking pressure, with the stock falling 3.55% on Friday amid broader market weakness. The stock remains below its 52-week high of Rs.154.85, indicating valuation headroom but also potential volatility. The company’s Mojo Grade remains at Sell with a score of 40.0, suggesting that while improvements are underway, risks persist. Investors should remain mindful of margin pressures and regulatory factors impacting the Pharmaceuticals & Biotechnology sector.
Conclusion
Amanta Healthcare Ltd’s performance this week was characterised by a strong quarterly earnings report and an upgraded financial trend, which supported gains early in the week. Despite some profit-taking and market weakness towards the end, the stock managed to outperform the Sensex, closing with a modest weekly gain of 0.67%. The company’s improved profitability metrics and operating efficiency mark a positive shift from previous quarters, although the Mojo Grade of Sell indicates ongoing caution. Overall, the week’s developments suggest a stabilising business outlook amid a challenging sector environment, with investors advised to monitor upcoming financial updates and market conditions closely.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
